Skip to main content
Caplight Logo









ClairLabs

ClairLabs

Private
Tel AvivHealthcare & Life Scienceshttps://clairlabs.ai/

Last Round

Seed

Jun 18, 2021

Total Funding Raised

$9M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ClairLabs operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Seed round in June 2021.

ClairLabs is a healthtech company that provides a platform integrating multi-omics, AI, and cloud engineering to transform health data into insights for life sciences, biopharma, and diagnostics organizations.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Precision Medicine, Healthcare Analytics, Clinical Trials, Data Integration

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

ClairLabs Comparables

Compare ClairLabs with similar companies based on industry and business-model similarity.

ClairLabs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioLizard
87%
Ardigen
80%
Sequentia Biotech
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

ClairLabs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 18, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

ClairLabs Investors

Notable investors and investment history

ClairLabs investors
InvestorRounds
Maniv MobilitySeed
10DSeed
Supermoon CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 5, 2.5x the trailing average.

  • Apr 27, 2026

    Grew 25% QoQ, from 24 to 30 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

ClairLabs Filings

Explore SEC and related filing metadata, where available.

ClairLabs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about ClairLabs's valuation, stock price, and market status.

Is ClairLabs a public or private company?

ClairLabs is a private company.

What is the current stock price of ClairLabs?

ClairLabs is a private company, so its shares have no public market price. Caplight tracks ClairLabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is ClairLabs worth (valuation)?

Valuation information for ClairLabs is not publicly available.

Can I buy ClairLabs stock?

ClairLabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was ClairLabs's last funding round?

ClairLabs's most recent funding round was Seed on June 18, 2021.

Who are the main investors in ClairLabs?

Key investors in ClairLabs include 10D.

Will ClairLabs IPO soon?

No public IPO plans have been announced for ClairLabs.

How can I track ClairLabs secondary market activity?

Caplight tracks bids, offers, and trades in ClairLabs's shares on secondary markets.

Firmographic Details

HeadquartersTel Aviv
Employee Range28
Year Founded2018
Last FundingJun 18, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?